Company and Vaccine or Product

Date of License

Date of Revocation

Tetanus toxoid

09/22/1959

02/06/1979

Tetanus & diphtheria toxoids adsorbed (for adult use)

07/27/1970

02/06/1979

Typhoid

07/11/1950

02/06/1979

University of Illinoisa

 

 

BCG vaccine

07/07/1950

05/29/1987

Wellcomed

 

 

Rubella virus, live

03/01/1977

 

Wyeth Laboratories

 

 

Adenovirus, live, oral, type 4

07/01/1980

 

Adenovirus, live, oral, type 7

07/01/1980

 

Cholera

07/16/1952

 

Diphtheria & tetanus toxoids and pertussis vaccine adsorbed

09/11/1970

 

Diphtheria toxoid

05/19/1944

05/19/1987

DT, adsorbed

09/11/1970

 

Influenza

12/13/1961

 

Pertussis vaccine

07/16/1952

05/19/1987

Rabies vaccine

08/11/1982

08/07/1986

Smallpox

05/19/1944

 

Tetanus toxoid

05/19/1944

 

Tetanus toxoid, adsorbed

09/11/1970

 

Tetanus & diphtheria toxoids adsorbed (for adult use)

09/11/1970

 

Typhoid

07/16/1952

 

a Company no longer produces any vaccines.

b Connaught Laboratories, Inc., (U.S.) and Connaught Laboratories, Ltd (Canada), are subsidiaries of Pasteur-Mérieux Sérums et Vaccins (France).

c Evans-Medical is a division of Medeva International, plc (United Kingdom); Medeva International plc acquired the vaccine business from Wellcome in 1991.

d Lederle Laboratories acquired Praxis Biologics in 1989. Lederle-Praxis Biologicals is now a business unit of American Cyanamid.

e Company produces one vaccine only for U.S. market.

f Sclavo spa is now owned by Ciba-Geigy (Switzerland) and Chiron (U.S.).

SOURCE: Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement